How did EDAP's Q1 2024 earnings surprise impact short-term trading?

**EDAP's Q1 2024 earnings surprise had a positive impact on short-term trading**, as evidenced by the following:

1. **Revenue Growth**: EDAP reported record preliminary unaudited revenue of EUR 60.4 million for full-year 2023, an increase of 9.6% over full-year 2022. This growth was driven by significant increases in HIFU (High-Intensity Focused Ultrasound) growth, with a 31.7% increase in HIFU. The strong revenue growth likely contributed to investor confidence and positive market sentiment.
2. **Focal One System Sales**: EDAP announced preliminary Focal One placement results for the fourth quarter, placing twelve Focal One systems, inclusive of ten capital sales. The robust demand for Focal One robotic HIFU technology and the record quarter for sales indicate a strong market demand, which could have positively influenced investor sentiment.
3. **Stock Performance**: Despite missing EPS estimates by -15 cents, EDAP's revenue exceeded expectations, with a 8.20% better revenue report compared to estimates. This beat on revenue likely overshadowed the EPS miss, contributing to a positive market reaction.

In conclusion, EDAP's Q1 2024 earnings report, with its emphasis on revenue growth and strong Focal One system sales, likely created a positive short-term trading environment, as investors responded favorably to the company's performance and market expansion.